Clinical trial

Diabetes Prevention Program in Schizophrenia [DPPS]

NCT00182494 · Hamilton Health Sciences Corporation, Other · Unknown status

Key facts

NCT number NCT00182494
Title Diabetes Prevention Program in Schizophrenia [DPPS]
Official title A Five Year, Prospective, Randomized, Blinded, Controlled Trial Comparing the Efficacy of a Modified Diabetes Prevention Protocol and the Standard Comprehensive Outpatient Care in Lowering the Incidence of New Onset Diabetes Among People Treated for Schizophrenia and Are at Risk to Develop Type II…
Lead sponsor Hamilton Health Sciences Corporation, Other
Collaborators The Lawson Foundation Ontario Mental Health Foundation
Status Unknown status
Phase Phase 4
Study type Interventional
Conditions Diabetes Mellitus, Schizophrenia
Intervention type Behavioral
Interventions Modified diabetes prevention protocol & Metformin
Enrollment 200
Start date Feb 1, 2005
Completion Jan 1, 2009
First posted Sep 16, 2005
Last update posted Sep 16, 2005
Countries Canada

At a glance

  • 1–9 Study sites
  • No Results posted
  • None Linked FDA submissions

Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.

About ClinicalTrials.gov studies

ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.

Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date:

Browse all ClinicalTrials.gov studies